CHE
Chemed Corporation
SERVICES-HOME HEALTH CARE SERVICES
Chemed (CHE) Stock: Buy, Sell, or Hold?
$550.20
-0.42 (-0.08%)
▼
5d:
+3.08%
30d:
+7.21%
90d:
+3.25%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
46/100
Position
EXTENDED
30-Day Fair Range
$505.21 – $538.48
Position: EXTENDED
Forward P/E & Valuation
19.8x
FAIR
vs 17.3x historical avg
Wall Street Target
$617.00
+12.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$521.65 / $557.64
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CHE shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$645.99
Based on 6.1% avg growth
INTRINSIC VALUE TODAY
$401.11
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $550.20, which is considered extended relative to its 30-day fair value range of $505.21 to $538.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.8) compared to its historical average (17.3). At these levels, the market is pricing in 4.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $557.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $617.00 (+12.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $557.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $617.00 (+12.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$505.21 -
$538.48
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
Trading Range & Key Levels
30-Day Trading Range
$505.21 -
$538.48
Current vs Trading Range
EXTENDED
Support Level
$521.65
Resistance Level
$557.64
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($617.00)
- NEUTRAL: Market pricing in 4.5% annual earnings growth - fairly valued
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.76
Wall Street Target
$617.00
(+12.1%)
Revenue Growth (YoY)
10.6%
Earnings Growth (YoY)
22.2%
Profit Margin
10.6%
Valuation Premium vs History
+4.5% premium
PE vs Historical
19.8 vs 17.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.5%
(market-implied from PE analysis)
1-Year Target
$574.96
(+5%)
2-Year Target
$600.83
(+9%)
3-Year Target
$627.87
(+14%)
3-Yr Target (if PE normalizes)
(PE: 20→17)
PE COMPRESSION
$549.83
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.1%)
$697.75
(+27%)
Base:
(SPY PE: 19.8, Growth: 8.1%)
$694.08
(+26%)
Bear:
(PE: 16.8, Growth: 8.1%)
$589.97
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.37 | Current EPS (TTM): $20.88
Bull Case
$807.88
(+47%)
Analyst growth 33.4%, PE expands to 29.0
Base Case
$734.43
(+34%)
Market implied 33.4%, PE stable at 26.4
Bear Case
$374.42
(-32%)
Severe decline -20.0%, PE contracts to 22.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CHE Analysis
Share this live CHE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CHE)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Chemed (CHE) reported Q3 earnings of $6.75 per share, surpassing estimates and revenues of $690.94 million, also exceeding expectations.
Key Retail Themes:
Chemed beat both earnings and revenue estimates for the third quarter of 2026.
The company has surpassed consensus estimates for earnings and revenues in the last four quarters.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:12 PM ET
Data refreshes hourly during market hours. Next update: 8:12 PM
Data refreshes hourly during market hours. Next update: 8:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 39 SELL |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 31 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 45 HOLD |
|
PNTG
Pennant Group Inc |
STRONG BUY
7 analysts |
$48 | 64 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CHE Research Pages